{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-060600","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2026-05-22T20:30:28+00:00","discovered_at":"2026-05-22T20:33:00.300582+00:00","generated_at":"2026-05-22T20:47:03.594220+00:00","sec_items":["4.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"confidence":"high","headline":"NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance","bullets":["Revenue overstated by ~$0.5M, net loss understated by ~$0.3M for quarter ended March 31, 2026.","Restatement caused by customer order modification at quarter-end; no prior periods affected.","Company reaffirms FY2026 product revenue guidance of at least $10.5M.","Internal control weakness identified; measures to improve controls are being implemented.","Audit Committee determined non-reliance on previously filed Form 10-Q for March 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-060600","json":"https://secwatch.observer/filing/0001213900-26-060600.json","markdown":"https://secwatch.observer/filing/0001213900-26-060600.md","text":"https://secwatch.observer/filing/0001213900-26-060600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026060600/0001213900-26-060600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026060600/ea0291925-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T20:47:03.594220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}